stockhead1d
Resources Top 5: Explorers desperate to drill as gold prices ride high
BMG Resources (ASX:BMG) and Metal Hawk (ASX:MHK) are preparing to drill down on gold projects in WA's northern Goldfields.
3 megatrends accessible via the Vanguard MSCI Index International Shares ETF (VGS)
The ASX VGS makes it easy to invest in several global investment megatrends via a single trade. The post 3 megatrends ...
Japan Today14d
Asia shares mostly decline as investors await earnings, U.S. elections
Australia's S&P/ASX 200 slipped 0.3% to 8,160.00 ... which sank 6.3% amid concerns about two of the drugmaker’s blockbuster products: diabetes treatment Mounjaro and weight loss counterpart Zepbound.
Philippine Daily Inquirer14d
Asia shares decline as investors await earnings, US elections
Australia’s S&P/ASX 200 slipped 0.3% to ... about two of the drug maker’s blockbuster products: diabetes treatment Mounjaro and weight loss counterpart Zepbound. Also falling was Trump Media ...
stockhead15d
Market Highlights: Gold hits new highs while Meta misses the mark; and 5 ASX small caps to watch
Drugmaker Eli Lilly‘s stock tumbled by 6% after the company missed profit and revenue expectations for Q3 primarily due to ...
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound ...
Stock market today: Nasdaq edges back from its record as chip companies and Eli Lilly slump
U.S. stock indexes edged lower after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company.
NBC Connecticut15d
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
But those wholesalers tapped into some of that existing stock in the third quarter instead of buying more from the company, which dampened revenue from both treatments, Eli Lilly said. Mounjaro ...